Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy

Abstract excerpt

The development of DNA microarray technologies over the past decade has revolutionised translational cancer research. These technologies were originally hailed as more objective, comprehensive replacements for traditional histopathological cancer classification systems, based on microscopic morphology. Although DNA microarray-based gene expression profiling (GEP) remains unlikely in the near term to completely...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Glioma Diagnosis and Treatment
• Share to MicroRNA in disease regulation
• Share to Single-cell and spatial transcriptomics